Phreesia Inc

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Phreesia reports strong Q1 earnings, sees growth in Medicare market

Phreesia's Q1 2023 earnings call highlighted strong performance, maintained revenue outlook, and raised adjusted EBITDA outlook. The company faces challenges from labor market changes and pricing experimentation but sees opportunities in product growth, client adds, and patient insights application.

Phreesia reports strong Q2 2024 earnings and strategic acquisitions

Phreesia's Q2 2024 performance reflects strong revenue growth and strategic outlook, despite challenges related to client adds and subscription revenue. The company's focus on achieving profitability beyond fiscal 2025 and strategic acquisitions positions it for long-term value creation. Balancing growth and investment, as well as navigating seasonality and external events, are key considerations for Phreesia's future.

Phreesia reports Q3 2024 revenue of $91.6 million, delays revenue target to prioritize EBITDA growth

Phreesia's Q3 2024 earnings call highlighted strong revenue performance, an acquisition enhancing patient experience, and a strategic decision to delay revenue targets to prioritize EBITDA growth. The company maintains a focus on innovation, customer satisfaction, and sustainable financial performance, while also addressing short-term financial challenges and positioning for significant revenue and profitability growth in fiscal 2025.

Phreesia reports robust Q4 earnings, eyes growth in healthcare solutions

Phreesia Inc's Q4 2023 performance reflects strong revenue growth and client base expansion, positioning the company for future profitability and stability.
With a focus on client value, strategic acquisitions, and operational efficiency, Phreesia navigates challenges in the healthcare industry to drive long-term growth.
Opportunities in network solutions, payer space, and margin improvement present avenues for Phreesia to capitalize on market trends and enhance shareholder value.

Phreesia Inc reports strong Q1 earnings, eyes revenue growth

Phreesia Inc's Q1 2024 performance reflects robust revenue growth and client expansion, with a positive outlook for fiscal 2024 and ambitious targets for fiscal 2025.
While facing challenges such as potential growth deceleration and labor market impacts, the company remains focused on innovation, client satisfaction, and profitability.
Opportunities in new revenue streams, partnerships, and payment technologies present avenues for Phreesia to drive future growth and market leadership.

Phreesia Inc reports robust Q2 performance and targets fiscal growth

Phreesia Inc's Q2 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic targets for fiscal 2024 and 2025, underpinned by investments in client value and growth strategies.
While facing challenges in the sales cycle and cost controls, the company remains focused on achieving profitability and free cash flow without additional capital beyond fiscal '25.
Opportunities in product introductions, customer service enhancements, and market expansion present avenues for sustained growth and value creation for Phreesia.

Phreesia reports robust Q3 performance, shifts focus to profitability

Phreesia Inc's Q3 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic acquisitions, underlining the company's positive trajectory.
While facing challenges in achieving profitability and managing investor expectations, Phreesia's focus on financial discipline and market expansion presents opportunities for sustainable growth.
The establishment of a new credit facility and clear guidance for fiscal 2024 and 2025 demonstrate Phreesia's commitment to financial stability and long-term value creation.

Phreesia reports strong Q4 revenue growth and focuses on profitability

Phreesia Inc's Q4 performance reflects revenue growth and improved EBITDA, with a focus on efficiency and client value to drive profitability.
Despite industry challenges, Phreesia's strengths in client growth strategies, network solutions revenue, and cash flow support its growth trajectory.
Balancing profitability goals with investments in growth, Phreesia navigates challenges while exploring opportunities in PAM, client value, and network expansion.
The company's outlook for FY 2025 underscores a commitment to sustainable growth through client additions, product enhancements, and operational efficiency.

Phreesia Inc reports strong Q1 earnings, eyes growth opportunities

Phreesia Inc's Q1 performance reflects a positive turnaround with revenue growth and adjusted EBITDA turning positive after 3 years. The company faces challenges from client relationship transitions but is leveraging opportunities in cybersecurity investments and revenue-driving products.

Phreesia Inc reports robust Q2 earnings and optimistic outlook

Phreesia Inc's Q2 2025 earnings call highlighted strong financial performance and positive outlook for fiscal 2025. While facing uncertainties around external factors and inorganic opportunities, the company remains focused on driving growth through AHSC expansion and revenue enhancement strategies.

Phreesia Inc reports robust Q3 earnings, eyes sustained growth

Phreesia Inc's Q3 performance reflects strong financial results and positive cash flows, underpinning its growth trajectory.
The company's revised outlooks for fiscal 2025 and initial guidance for 2026 signal confidence in sustained growth and profitability.
While balancing profitability and reinvestment poses challenges, Phreesia has opportunities to leverage network solutions, customer feedback, and strategic leadership for future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade PM360 has named David Linetsky, Senior Vice President of Life Sciences, as one of the 2021 PM360 ELITE 100. The ELITE Awards recognize the most influential people in the healthcare and life sciences industry today, and honorees were chosen from a pool of more than 500 submissions across 19 categories. The PM360 editorial staff selected winners based on their accomplishments and testimoni

Phreesia's David Linetsky Named a ‘Transformational Leader' in PM360's Elite 100

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Friday, June 4, 2021, at 8:30 a.m. Eastern Time to discuss the Company's fiscal first quarter 2022 financial results. A press release announcing the fiscal first quarter financial results will be issued after the close of market trading on Thursday, June 3, 2021. To participate in the company's live conference call and webcast, please dial (866) 211-4557, or (647) 689-6750 for international pa

Phreesia Sets Release Date for Fiscal First Quarter 2022 Financial Results

RALEIGH, N.C. & NEW YORK--(BUSINESS WIRE)--Phreesia, the nation's leader in patient intake, and the Ad Council, a nonprofit organization that produces, distributes and drives impact through public service communications, have partnered to bring the Ad Council's ongoing awareness campaign with the Alzheimer's Association directly to patients and caregivers. Initial results from the campaign extension show that over half the people who engaged with the campaign as they checked in for a healthcare

Phreesia and Ad Council Partnership Yields High Engagement in Alzheimer's Awareness Campaign

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (the “Company”) (NYSE:PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,175,000 shares of its common stock (the “Offering”) all of which were sold by the Company, which includes the full exercise of the underwriters' option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of $50.00 per share and were purchased by the underwri

Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the “Offering”) at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public o

Phreesia Announces Pricing of Public Offering of Common Stock

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is sub

Phreesia Announces Proposed Public Offering of Common Stock

Phreesia, Inc. (PHR) CEO Chaim Indig on Q4 2021 Results - Earnings Call Transcript

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2021. "Our team's strength and resilience throughout a challenging fiscal 2021 supported our clients and helped drive our financial results. We are proud to support the incredible ongoing efforts of healthcare providers across the country while furthering Phreesia's mission of creating a better, more engaging healthcare experie

Phreesia Announces Fiscal Year End 2021 Results

RALEIGH, N.C. & NEW YORK--(BUSINESS WIRE)--Phreesia, the nation's leading patient intake platform, is pleased to announce it has partnered with the CONVINCE USA initiative at the CUNY Graduate School of Public Health & Health Policy (CUNY SPH) to create a patient survey and data-driven education tool to better understand and address patients' COVID-19 vaccine hesitancy. To date, more than 300,000 survey responses have been collected across Phreesia's nationwide network, providing valuable i

Phreesia Partners with CONVINCE USA on Vaccine Hesitancy Initiative

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will issue a press release that includes the company's fiscal fourth quarter and full year 2021 financial results after the close of market trading on Tuesday, March 30, 2021. The Company will host a conference call and webcast to review the quarterly results on Wednesday, March 31, 2021, at 8:30 a.m. Eastern Time. To participate in Phreesia's live conference call and webcast, please dial (866) 211-4557, or (647) 689-6750 f

Phreesia Sets Release Date for Fiscal Fourth Quarter and Full Year 2021 Results

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia today announced it has been named 2021 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2021 Best in KLAS: Software and Services,” KLAS recognized the industry's top-performing healthcare IT and services companies, based on feedback from healthcare organizations. “Each year, thousands of healthcare professionals across the globe take the time to share their voice with KLAS,” said KLAS President Ada

Phreesia Named 2021 Best in KLAS for Patient Intake Management

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, the nation's leading patient intake management platform, is pleased to announce that it is one of 380 companies across 11 sectors included in the 2021 Bloomberg Gender-Equality Index (GEI). The GEI expanded in 2021 to represent 44 countries and regions, including firms headquartered in Indonesia and Bermuda for the first time. Companies range from a variety of industries, including automotive, banking, consumer services, engineering and construction, an

Phreesia Named to 2021 Bloomberg Gender-Equality Index, Highlighting Its Commitment to an Inclusive Workplace

RALEIGH, N.C. & ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--Phreesia, the nation's leading patient intake platform, is pleased to announce that as a result of ongoing auditing by the Alliance for Audited Media (AAM), the industry leader in media verification, it has received certification from the Point of Care Communication Council (PoC3) validating that the advertising measurement systems and methods of its digital point-of-care engagement platform comply with the highest industry standards. Ph

Phreesia Receives Certification from the Point of Care Communication Council, Based on Audit by the Alliance for Audited Media

Phreesia (PHR) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Phreesia (PHR) in Focus: Stock Moves 5.5% Higher

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, the nation's leading patient intake platform, is pleased to announce that it is now listed on the Zoom App Marketplace, expanding provider access through its Intake for Telehealth offering. Through the integration of Zoom with Phreesia's platform, we offer an automated solution that streamlines and simplifies patient intake during telehealth visits. “Joining the Zoom App Marketplace allows us to extend and expand our support to providers across the coun

Phreesia Joins Zoom App Marketplace to Create a Better Telehealth Experience

FORT WASHINGTON, Pa. & RALEIGH, N.C.--(BUSINESS WIRE)--Office Practicum (OP), a leading provider of pediatric-specific EHR, practice management and revenue cycle management solutions, and Phreesia, the nation's leading patient intake management platform, are pleased to announce that they have partnered to offer robust, bidirectional integration between their systems, helping pediatric groups improve operations and create the healthcare experience that parents and families want. "This partnershi

Office Practicum and Phreesia Partner to Offer Seamlessly Integrated Patient Intake to Pediatric Practices

Phreesia, Inc.'s (PHR) CEO Chaim Indig on Q3 2021 Results - Earnings Call Transcript

Shares of Phreesia (NYSE:PHR) moved lower by 10.4% after the company reported Q3 results. Quarterly Results Earnings per share were down 28.57% year over year to ($0.09), which were in line with the estimate of ($0.09).

Phreesia: Q3 Earnings Insights

NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) today announced that Tom Altier, its Chief Financial Officer, will retire in April 2021. Randy Rasmussen, the company's Chief Accounting Officer, will succeed Altier as CFO, effective May 1, 2021. Altier, who joined Phreesia in 2012, will continue in his current role through the end of April 2021 and the filing of Phreesia's Annual Report on Form 10-K, and thereafter will continue to support the company in an advisory role. “Tom's leadership

Phreesia Announces Planned CFO Transition in 2021: Chief Financial Officer Tom Altier to Retire, Randy Rasmussen Named New CFO

NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal third quarter ended October 31, 2020. "Our third quarter results reflect our entire team's commitment to our clients and Phreesia's mission of creating a better, more engaging healthcare experience,” said Phreesia CEO Chaim Indig. Fiscal Third Quarter 2021 Highlights Revenue was $38.5 million in the quarter as compared to $32.8 million in the same period in the prior year, an incr

Phreesia Announces Fiscal Third Quarter 2021 Results

NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will issue a press release that includes the company's fiscal third quarter 2021 financial results after the close of market trading on Tuesday, December 8, 2020. Phreesia will host a conference call and webcast on Wednesday, December 9, 2020, at 8:30 a.m. Eastern Time to review the quarterly results. To participate in the Phreesia's live conference call and webcast, please dial (866) 211-4557, or (647) 689-6750 for internationa

Phreesia Sets Release Date for Fiscal Third Quarter 2021 Results

NEW YORK--(BUSINESS WIRE)--Phreesia is honored to be recognized by the research and insights firm KLAS as the patient intake management solution with the highest overall score and the highest COVID-19 response rating in a new report entitled, “Patient Intake Management 2020: Helping Clinics Keep Their Doors Open During COVID-19.” “KLAS is a deeply respected organization whose reports are the industry standard and we're thrilled that they've recognized us as top performer, especially since their

Phreesia Recognized for Highest Overall Performance in New KLAS Report on Patient Intake Management Solutions

NEW YORK--(BUSINESS WIRE)--Phreesia, the nation's leading patient intake platform, is pleased to announce that Kristin Roberts, the company's Vice President of Market Development, has been named to The Software Report's list of the Top 50 Women Leaders in SaaS of 2020. Honorees were selected for their contributions to their respective companies and demonstrated expertise in the field, following a rigorous review of both their professional backgrounds and nominations from colleagues and peers. T

Phreesia's Kristin Roberts Named a Top Woman Leader in SaaS

Investors are confident about the company's prospects after its strong secondary stock offering pricing.

Why Phreesia Stock Is Flying Higher Today

Target

Applied UV

OLB Group

The Covid-19 pandemic has significantly impacted the way people are living their lives these days. This has led to a number of behavioral changes in the life of the average consumer, and one new aspect that has particularly gained importance is the use of zero-contact solutions.

News for Phreesia Inc Stock (PHR)